Health Care & Life Sciences » Biotechnology | Shenzhen CAU Technology Co. Ltd.

Shenzhen CAU Technology Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
70,357.80
75,779.80
113,996.60
254,993.80
135,455.30
Cost of Goods Sold (COGS) incl. D&A
36,136.20
50,804.50
78,907.30
189,372.80
53,681.50
Gross Income
34,221.60
24,975.30
35,089.30
65,621.00
81,773.80
SG&A Expense
22,859.60
21,102.80
25,236.00
37,905.70
88,388.20
EBIT
10,930.30
3,328.60
9,075.90
27,846.00
6,614.40
Unusual Expense
1,384.30
17,094.00
-
5,209.40
919.60
Non Operating Income/Expense
788.70
489.30
1,355.70
26,156.00
256.40
Interest Expense
-
153.40
300.20
3,531.80
-
Pretax Income
11,203.00
20,665.80
10,808.60
46,185.70
9,716.40
Income Tax
5,406.30
5,041.00
3,951.50
6,469.40
3,824.20
Consolidated Net Income
5,796.80
15,624.80
6,857.20
39,716.30
5,892.20
Net Income
1,033.40
3,801.40
1,247.10
39,299.30
8,566.70
Net Income After Extraordinaries
1,033.40
3,801.40
1,247.10
39,299.30
8,566.70
Net Income Available to Common
1,033.40
3,801.40
1,247.10
39,299.30
8,566.70
EPS (Basic)
0.01
0.05
0.01
0.47
0.10
Basic Shares Outstanding
83,976.70
83,976.70
83,976.70
83,976.70
83,976.70
EPS (Diluted)
0.01
0.05
0.01
0.47
0.10
Diluted Shares Outstanding
83,976.70
83,976.70
83,976.70
83,976.70
83,976.70
EBITDA
16,402.60
8,433.00
14,242.90
32,381.00
2,052.30
Other Operating Expense
431.70
543.80
777.30
130.60
-
Non-Operating Interest Income
868.30
885.80
542.30
924.90
15,154.70
Minority Interest Expense
6,830.10
11,823.40
5,610.00
417.00
2,674.50

About Shenzhen CAU Technology Co.

View Profile
Address
Room 503, China Railway South
Shenzhen Guangdong 518045
China
Employees -
Website http://www.sz000004.cn
Updated 07/08/2019
Shenzhen Cau Technology Co., Ltd. engages in the development and sale of pharmaceutical products and real estate. The company also provides property management services. It operates through the following business areas: Biomedicine, Property management, Real estate, and Other.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.